May 10, 2016 | Net Health

1 min read

The Strategic View of Modified Stage 2 Meaningful Use: Part 5

Objective 9: Public Health Reporting/Measure Option 1—Immunization Registry Reporting

As in subsequent columns, we are continuing to review the objectives and measures for Modified Stage 2 Meaningful Use set forth from 2015 through 2017. In this column, you will find information detailing Objective 9: Public Health Reporting. You will note there are 3 Measure Options within Objective 9. Measure Option 1, which is available on p. 20 at http://go.cms.gov/25GPZcI, focuses on Immunization Registry Reporting. Measure Objective 2: Syndromic Surveillance Reporting and Measure Objective 3: Specialized Registry Reporting will be discussed in future columns. The specific Public Health Reporting Measures provide epidemiological statistics and help to monitor population health more accurately. There are different options for reporting each select measure, and the eligible professional (EP) should research his/her Public Health Reporting Options from the state in which they are attesting.

The Centers for Medicare & Medicaid Services provided a detailed explanation (FAQ 2985)1 for reporting the measures:

“In the final rule at 80 FR 62788, we discuss our final policy to allow for alternate exclusions and specifications for certain objectives and measures where there is not a Stage 1 measure equivalent to the Modified Stage 2 (2015 through 2017) measure or where a menu measure is now a requirement. This includes the public health reporting objective as follows.

Read the full article in Advances in Skin & Wound Care.

This article was originally published in Advances in Skin & Wound Care, written by Cathy Thomas Hess, BSN, RN, CWCN, VP and Chief Clinical Officer for Wound Care at Net Health.

Share this post

Subscribe and See More